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DNA from gastrointestinal biopsy specimens from 28 Australian patients with histologic evidence of intes-
tinal spirochetosis (IS) was subjected to PCRs to amplify segments of the 16S rRNA and NADH oxidase genes
of Brachyspira aalborgi and Brachyspira (Serpulina) pilosicoli. B. aalborgi was identiﬁed in specimens from 24
(85.7%) patients and B. pilosicoli in those from 4 (14.3%) patients (2 of whom were also positive for B. aalborgi).
For two patients, no product was ampliﬁed. This study demonstrates that B. aalborgi is much more commonly
involved in histologically identiﬁed IS in Australian patients than is B. pilosicoli. This is the ﬁrst report of
ampliﬁcation of B. pilosicoli DNA from humans with IS.
Since the ﬁrst histologic description of intestinal spirochet-
osis (IS) in 1967 (3), diagnosis of the condition has been prob-
lematic. Clinical microbiologists have had difﬁculty culturing
the causal spirochetes; consequently, IS has been predomi-
nantly diagnosed on the basis of histologic ﬁndings in biopsy
material. The characteristic diagnostic feature is the presence
of a thin, carpet-like layer of spirochetes attached by one cell
end to the colorectal surface epithelium. The colonization is
often not associated with signiﬁcant changes in the underlying
mucosa, and unless the specimen is examined at a 1,000-fold
magniﬁcation, the spirochetes may go unnoticed. Since co-
lonoscopy with or without biopsy is relatively routine only in
afﬂuent western societies, the histologic identiﬁcation of IS has
been predominantly in developed countries.
Two spirochete species, Brachyspira aalborgi (4) and Brachy-
spira (Serpulina) pilosicoli (12, 14), have been implicated as
causal agents of IS in humans. The relative involvement of the
two species in IS in different groups of patients is unclear, and
it is not known whether both species have similar pathogenic
potential. Both are slow-growing anaerobes requiring special-
ized media and prolonged incubation, but B. pilosicoli is much
easier to isolate than B. aalborgi. Perhaps because of this dif-
ference, B. pilosicoli is currently recognized as a pathogen
of the large intestine in various animal species (14), while
B. aalborgi has only been demonstrated by PCR in macaques
and humans (2, 11). By using specialized culturing techniques
on human feces, rather than histologic examination, B. pilosi-
coli has been shown to commonly colonize (.30% prevalence)
Australian Aboriginal children (8), Gulf Arabs (1), villagers in
Papua New Guinea (13), and homosexual males and human
immunodeﬁciency virus (HIV)-positive patients in Western
societies (9, 12). However, it is not clear whether these indi-
viduals also have histologic IS caused by B. pilosicoli. There is
only one report where concurrent histologic and microbiologic
investigation has demonstrated the involvement of B. pilosicoli.
In this study, involving Australian homosexual males, B. pilosi-
coli was isolated from 50% of rectal biopsy specimens that
showed histologic attachment of spirochetes to the mucosa (12).
Currently there are only two reports, both from Scandinavia,
of B. aalborgi having been cultured from biopsy samples from
patients with IS (4, 7). Consequently, the relative importance
of B. aalborgi as an etiologic agent of IS has been uncertain.
However, in a recent study, PCRs were carried out on DNA
extracted from human colorectal biopsy tissue obtained from
16 patients, mainly from Norway, who had histologic evidence
of IS (11). B. aalborgi was detected in 10 of the patients (63%),
while B. pilosicoli was not detected in any individual. This
ﬁnding suggests that B. aalborgi may be the main agent of
histologic IS in nonhomosexual Caucasian populations, partic-
ularly in Scandinavian countries.
In the Australian context, we have used selective culture to
examine specimens from relatively narrow population groups,
and we concluded that colonization with B. pilosicoli was com-
mon in rural Aboriginal children, and in homosexual males in
Sydney, but was virtually absent from children in the cities of
Perth and Darwin (8, 12). The purpose of the present study was
to broaden our understanding of the relative importance of the
two spirochete species in Australia by using the PCR technique
on retrospective archival biopsy material from a relatively large
number of nonselected, mainly urban adult patients with both
histologic IS and gastrointestinal symptoms.
Permission for this study was obtained from the Murdoch
University Human Ethics Committee and the ethics commit-
tees of the hospitals involved. Sixty-nine formalin-ﬁxed routine
biopsy samples from 28 Australian patients with histologic
diagnoses of IS were examined (Table 1). The majority of the
patients resided in cities: 14 in Perth, Western Australia (WA),
7 in Darwin in the Northern Territory, and 1 in Melbourne,
Victoria. The other six patients lived in relatively remote small
rural towns and communities throughout WA. Two of the
patients from Perth were HIV positive. The number of samples
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347TABLE 1. Sources of the intestinal samples from 28 Australian patients diagnosed with IS, and subsequent PCR results










Results for 16S rRNA
and nox PCRs
B. aalborgi B. pilosicoli
Perth, WA F, 35 12-yr ulcerative-colitis disease
history; inactive at time of
biopsy
Cecum IS 12
Transverse colon Minor changes 12
Ascending colon IS 12
Hepatic ﬂexure IS 12
Splenic ﬂexure IS 12
Sigmoid IS 12
Rectum IS 12
Perth, WA F, 41 Diarrhea; O/E ulcers Colon at 130 cm IS; inﬂammation 12
Colon at 80 cm IS; active inﬂammation 12
Rectum IS; active inﬂammation 12
Perth, WA F, 49 Diarrhea Duodenum Negative 22
Random colon IS; lymphocyte aggregates 12
Perth, WA F, 53 Polyps Cecum IS 12
Transverse colon IS 12
Descending colon IS 12
Hepatic ﬂexure IS 12
Sigmoid colon IS 12
Rectum IS 12
Perth, WA F, 56 Altered bowel habit Rectum IS; lymphocyte aggregates 12
Perth, WA M, 25 Epigastric pain; lower
abdominal cramps




Colon at 80 cm IS; minor changes 12
Colon at 35 cm IS; inﬂammation 12
Rectum IS; minor lymphocyte aggregates 12
Perth, WA M, 29 Right iliac fossa pain Appendix IS 12
Appendix IS 12
Perth, WA M, 35 Anemia Gastric antrum Negative 22
Duodenum Negative 22
Terminal ileum Negative 22
Right colon IS; lymphocyte aggregates 12
Left colon IS; lymphocyte aggregates 12
Rectum Minor changes 22
Rectal polyp Adenoma 22
Perth, WA M, 36 HIV
1; homosexual Liver Negative 22
Sigmoid IS; minor changes; lymphocyte aggregates 12
Anal canal Inﬂammation; ﬁbrosis; no dysplasia 22
Perth, WA M, 43 Not recorded Rectum IS; active inﬂammation; CMV 12
Perth, WA M, 81 Gastritis Gastric antrum Gastritis 22
Cecum IS; minor changes 12
Ascending colon IS; minor changes 12
Transverse colon IS 12
Splenic ﬂexure IS 12
Descending colon IS 12
Sigmoid colon IS 12
Rectum IS 12
Denmark, WA F, 52 Polyp Transverse colon IS 12
Bridgetown, WA M, 27 Rectal bleeding; pain;
proctitis
Ileum Normal 22
Descending colon IS 12
Right colon IS 12
Rectum Proctitis 22
Port Headland, WA M, 27 Rectal bleeding Rectum IS; minor changes 12
Rectum IS 12
Geraldton, WA M, 35 Ulcerative proctitis Rectum IS; lymphocyte aggregates 12
Kalgoorlie, WA M, 36 Diarrhea; congestion Rectum IS; minor changes; lymphocyte aggregates 12
Darwin, NT F, 25 Rectal bleeding Sigmoid colon IS; inﬂammation; tubular adenoma
formation; mild epithelial atypia
12
Darwin, NT F, 47 1-yr history of intermittent and
mild right iliac fossa pain
Colon IS; metaplastic polyps 12
Darwin, NT F, 47 Irritable bowel Cecum IS; associated mild increase in eosinophils
within lamina propria
12
Darwin, NT M, 35 Bloody diarrhea; diverticulitis? Colon IS 12
Darwin, NT M, 45 Rectal bleeding Rectum IS 12
Melbourne, Vic F, 51 Not recorded Colon IS 12
Wyndham, WA M, 36 Trauma-ischemia Appendix IS 11
Transverse colon IS 12
Darwin, NT M, 47 Not recorded Mid-transverse colon IS; hyperplastic polyps 11
Perth, WA M, 30 HIV
1; diarrhea Sigmoid colon IS; mild nonspeciﬁc inﬂammatory changes 21
Darwin, NT F, 16 Appendicitis Appendix IS; acute appendicitis 21
Perth, WA F, 67 Diarrhea Ascending colon Minor changes 22
Transverse colon Possibly IS; minor changes 22
Sigmoid colon Adenoma 22
Perth, WA M, 38 Acute appendicitis? Appendix IS 22
a NT, Northern Territory; Vic, Victoria.
b F, female; M, male. Ages are given in years.
c CMV, cytomegalovirus.
348from any particular patient varied from one to seven and, for
comparative purposes, included samples from the liver, stom-
ach, and small intestine for six patients. Samples from the large
intestine were taken at various sites from the appendix through
to the anus. The patients were all suffering from a range of
gastrointestinal symptoms, which prompted endoscopy with
biopsy to aid diagnosis (Table 1).
DNA from parafﬁn-embedded tissue (PET) samples was
extracted using a modiﬁcation of a method previously de-
scribed (11). Several sections approximately 10 mm thick were
cut from the PET samples. Each sample was dewaxed with 400
ml of xylene and then an equivalent volume of 100% ethanol.
Samples were centrifuged at 10,000 3 g for 10 min, and the
supernatant was discarded. If residual parafﬁn was present, the
process was repeated. The samples were dried at 50°C in an
oven for at least 30 min. Twenty micrograms of proteinase K in
200 ml of 50 mM Tris-HCl, pH 8.3, was added and incubated
f o r1t o2ha t55°C, with occasional gentle mixing. The samples
then were boiled for 8 min, and 2 ml of each resultant extract
was used as template DNA for PCR analysis. The negative
controls, comprising biopsy specimens from patients without
histologic IS (n 5 14), were the same as those used in the
previous PCR study (11).
Speciﬁc PCR procedures amplifying portions of the 16S
rRNA and NADH oxidase (nox) genes of B. aalborgi and B.
pilosicoli were applied to the extracted DNA, as previously
described (11). The only exception was the use of a different
reverse primer (59-CCCCTACAATATCCAAGACT-39) for
the 16S rRNA PCR speciﬁc for B. pilosicoli. This produced a
larger, 439-bp product compared to the previous 196-bp prod-
uct. Ampliﬁcation mixtures were as previously described (11),
except that dimethyl sulfoxide was not added. The speciﬁcities
of the PCRs were conﬁrmed as previously described (11), by
ampliﬁcation of DNA extracted from a set of test organisms,
and by direct sequencing of eight selected amplicons from PET
giving ampliﬁcation in either B. pilosicoli or B. aalborgi 16S
rDNA or nox PCRs. In each case the product produced had a
sequence identical to or very closely related to the target se-
quence.
DNA from all 14 negative-control large-intestinal biopsy
specimens, and from all biopsy specimens taken from gastric or
small-intestinal tissue, failed to amplify in any of the PCRs.
Furthermore, there was no histologic evidence of IS in any of
these samples. Results for the samples from the 28 IS patients
are presented in Table 1. Where ampliﬁcation occurred, there
was perfect agreement between the results of 16S rRNA and
nox PCRs for both organisms. Two patients were positive for
both B. pilosicoli and B. aalborgi (7.1%). For one of these
patients, the appendix sample was positive for both organisms
but a concurrent transverse colon biopsy specimen was positive
for B. aalborgi only. For the other patient, a biopsy specimen
taken from the midpoint of the transverse colon was positive
for both species. One patient (3.6%), who was HIV positive,
was positive for B. pilosicoli alone in both PCRs. Histologically
it was not possible to distinguish B. pilosicoli from B. aalborgi in
the biopsy sections. Forty-eight specimens from 22 patients
(78.6%) were positive for B. aalborgi alone in both PCRs.
These positive samples came from various sites along the large
intestine from the appendix and cecum through to the rectum.
For eight patients multiple samples were taken along the large
intestine, including the rectum, and for ﬁve of these DNA was
ampliﬁed from B. aalborgi at all sites sampled, while three
(37.5%) patients had positive ampliﬁcations from the colon
samples and negative PCR results from the rectum samples.
Rectal biopsy specimens, therefore, do not necessarily reﬂect
the occurrence of IS in more proximal parts of the large intes-
tine, even where there is otherwise extensive colonization
along the tract.
Samples from two patients (7.1%) from Perth failed to am-
plify when any of the PCR protocols were applied. For one of
these patients, however, for whom multiple biopsy specimens
were tested, the histologic diagnosis of IS was uncertain (Table
1). Failure of ampliﬁcation for the other patient may have been
due to technical problems associated with obtaining appropri-
ate high-quality DNA, or it could have been the result of the
patient having been colonized by a different species of spirochete.
This is the ﬁrst report of direct detection of B. pilosicoli in
human colonic biopsy tissue using PCR. It is also the ﬁrst time
that both B. aalborgi and B. pilosicoli have been found concur-
rently colonizing humans with IS. Previously, concurrent col-
onization has been detected in macaques (2). It is possible that
other uncharacterized spirochete species were also present in
some patients; to investigate this possibility, it would be nec-
essary to use less species-speciﬁc primers and to sequence the
PCR product. Overall, B. aalborgi was the predominant species
detected in Australian patients with IS; it was present in 24
(85.7%) of the patients. This ﬁnding is in contrast to the ﬁnd-
ings of previous studies in Australia, using selective culture on
different population groups, where B. pilosicoli was commonly
isolated both from Aboriginal children and male homosexuals.
Such contrasting results from one country clearly indicate that
B. aalborgi and B. pilosicoli have very distinctive epidemiologic
patterns and infect different population groups. It is still not
known whether the two species have different pathogenic po-
tentials, and it will be necessary to obtain more biopsy samples
from patients colonized with B. pilosicoli before such compar-
isons can be made. It was also of interest that in this study B.
pilosicoli was identiﬁed in samples from the colon and appen-
dix, but not in the rectal biopsy specimens of any of the pa-
tients, whereas in the previous study on homosexual males it
was commonly isolated from rectal biopsy specimens (12).
The patients in the present study were not known to have
any increased risk factors for IS, apart from two who were
known to be HIV positive. One of the HIV-positive patients
was one of the four colonized by B. pilosicoli. Investigators in
Germany have reported recovering spirochetes resembling B.
pilosicoli from the feces of about half of a series of HIV
patients (6). The other HIV patient in this study, who was a
homosexual and a chronic hepatitis C virus carrier, was posi-
tive for B. aalborgi. This organism was previously identiﬁed by
the same PCR protocols in biopsy tissue from two HIV-posi-
tive patients with histologic IS from Washington, D.C. (11).
Hence HIV-positive patients may be colonized by either spe-
cies of spirochete.
Interestingly, the two patients who were colonized by both B.
pilosicoli and B. aalborgi came from Wyndham, a rural settle-
ment in the north of WA, and Darwin in the Northern Terri-
tory, respectively. Many Aboriginal people reside in these ar-
eas, but unfortunately ethical considerations prevented us
from obtaining speciﬁc information regarding the patients’ eth-
VOL. 39, 2001 NOTES 349nic identities. If these two patients were Aboriginal, the pres-
ence of B. pilosicoli would ﬁt with the known high (.30%)
prevalence of fecal carriage of B. pilosicoli by Aborigines in the
north of Australia (8). To date it has been difﬁcult to obtain
appropriate specimens to determine whether people with fecal
carriage of B. pilosicoli also show histologic evidence of IS.
Certainly a study from southern India, where 64% of normal
villagers showed attachment of spirochetes to the rectal mu-
cosa, suggests that people in developing countries (where B.
pilosicoli is commonly found in human feces) do often have
histologic IS (10). It is also worth noting that many pigs with
chronic diarrhea associated with B. pilosicoli infection do not
show end-on attachment of the spirochetes to the colonic mu-
cosa (5). A similar situation may occur in humans, in which
case chronic diarrhea and failure to thrive caused by B. pilosi-
coli (and perhaps B. aalborgi) would go undiagnosed because
the organism would not be detectable by histology or by the
inappropriate culture techniques currently routinely used in
medical diagnostic laboratories.
In summary, in this study B. aalborgi was shown to be a
common agent of histologic IS in Australian patients who had
undergone biopsy because of the presence of various relatively
nonspeciﬁc gastrointestinal symptoms. B. pilosicoli was identi-
ﬁed as an infrequent cause of IS in this group of patients, even
though this species has previously been shown to be a common
cause of histologic IS in Australian homosexuals (12). Simi-
larly, B. pilosicoli has been shown to commonly colonize Aus-
tralian Aboriginal children, but it is not known whether these
individuals also suffer from histologic IS. Further studies, per-
haps including techniques such as direct PCR on feces, are
required on these and other population groups to determine
the relative carriage rates and disease potentials of the two
spirochete species.
This study was supported by a grant from the National Health and
Medical Research Council of Australia.
Thanks are due to Jurgen Rode and Dale Fisher for providing
samples from patients in the Northern Territory, and to John Andrew
of Gribbles Pathology for providing the biopsy material from the
patient in Victoria.
REFERENCES
1. Barrett, S. P. 1990. Intestinal spirochaetes in a Gulf Arab population. Epi-
demiol. Infect. 104:261–266.
2. Duhamel, G. E., R. O. Elder, N. Muniappa, M. R. Mathiesen, V. J. Wong,
and R. P. Tarara. 1997. Colonic spirochetal infections in nonhuman primates
that were associated with Brachyspira aalborgi, Serpulina pilosicoli, and un-
classiﬁed ﬂagellated bacteria. Clin. Infect. Dis. 25:S186–S188.
3. Harland, W. A., and F. D. Lee. 1967. Intestinal spirochaetosis. Br. Med. J.
3:718–719.
4. Hovind-Hougen, K., A. Birch-Andersen, R. Henrik-Nielsen, M. Orholm,
J. O. Pedersen, P. S. Teglbjærg, and E. H. Thaysen. 1982. Intestinal spiro-
chetosis: morphological characterization and cultivation of the spirochete
Brachyspira aalborgi gen. nov., sp. nov. J. Clin. Microbiol. 16:1127–1136.
5. Jensen, T. K., K. Møller, M. Boye, T. D. Leser, and S. E. Jorsal. 2000.
Scanning electron microscopy and ﬂuorescent in situ hybridization of exper-
imental Brachyspira (Serpulina) pilosicoli infection in growing pigs. Vet.
Pathol. 37:22–32.
6. Ka ¨sbohrer, A., H. R. Gelderblom, K. Arasteh, W. Heise, G. Grosse, M. L’age,
A. Scho ¨nberg, M. A. Koch, and G. Pauli. 1990. Intestinale Spirocha ¨tose bei
HIV-Infektion. Dtsch. Med. Wochenschr. 115:1499–1506.
7. Kraaz, W., B. Pettersson, U. Thunberg, L. Engstrand, and C. Fellstro ¨m.
2000. Brachyspira aalborgi infection diagnosed by culture and 16S ribosomal
DNA sequencing using human colonic biopsy specimens. J. Clin. Microbiol.
38:3555–3560.
8. Lee, J. I., and D. J. Hampson. 1992. Intestinal spirochaetes colonizing Ab-
origines from communities in the remote north of Western Australia. Epi-
demiol. Infect. 109:133–141.
9. Lee, J. I., and D. J. Hampson. 1994. Genetic characterisation of intestinal
spirochaetes and their association with disease. J. Med. Microbiol. 40:365–
371.
10. Mathan, M. M., and V. I. Mathan. 1985. Rectal mucosal morphologic ab-
normalities in normal subjects in southern India: a tropical colonopathy?
Gut 26:710–717.
11. Mikosza, A. S. J., T. La, C. J. Brooke, C. F. Lindboe, P. B. Ward, R. G. Heine,
J. G. Guccion, W. B. de Boer, and D. J. Hampson. 1999. PCR ampliﬁcation
from ﬁxed tissue indicates frequent involvement of Brachyspira aalborgi in
human intestinal spirochetosis. J. Clin. Microbiol. 37:2093–2098.
12. Trivett-Moore, N. L., G. L. Gilbert, C. L. H. Law, D. J. Trott, and D. J.
Hampson. 1998. Isolation of Serpulina pilosicoli from rectal biopsy specimens
showing evidence of intestinal spirochetosis. J. Clin. Microbiol. 36:261–265.
13. Trott, D. J., B. G. Combs, A. S. J. Mikosza, S. L. Oxberry, I. D. Robertson,
M. Passey, J. Taime, R. Sehuko, M. P. Alpers, and D. J. Hampson. 1997. The
prevalence of Serpulina pilosicoli in humans and domestic animals in the
Eastern Highlands of Papua New Guinea. Epidemiol. Infect. 119:369–379.
14. Trott, D. J., T. B. Stanton, N. S. Jensen, G. E. Duhamel, J. L. Johnson, and
D. J. Hampson. 1996. Serpulina pilosicoli sp. nov., the agent of porcine
intestinal spirochetosis. Int. J. Syst. Bacteriol. 46:206–215.
350 NOTES J. CLIN.M ICROBIOL.